Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… PhD- or masters-level researchers, can help you: Select among potential product candidates and indications Determine … acceptance Gain reimbursement and Health Technology Assessment (HTA) approvals Differentiate your product FDAMA … and compliance; treatment switching, augmentation, and discontinuation; and outcomes associated with such measures …
… Utility Assessment Health utility estimates provide a representation … - Perform mapping to derive EQ-5D utility estimates from a disease-specific measure - Develop a health preference index … such as NICE, SMC, CDR, and PBAC), value messaging , and publications A Team Approach Let our multidisciplinary team …
… ICER’s 2023 Value Assessment Framework Updates: How Might Changes Impact Pharmaceutical Companies? Share on: July 28, … studies that support alternative value of the new therapy For long-term cost-effectiveness analyses, ICER …
… regulatory submissions, epidemiology studies, and drug, vaccine, and medical technology safety and … and combination products Selecting the best study design among alternative approaches Selecting the appropriate data … to use in regulatory discussions Advising on benefit-risk assessment methods for specific products Selecting analytic …
… Health Preference Assessment Do you know what your patients value and what they would be willing to trade-off … if your patient has to choose between a highly effective drug with a bad side effect profile and a less effective drug …
… Patient-Centered Outcomes Assessment Whether your goal is to support product claims, … communication, our Patient-Centered Outcomes Assessment (PCOA) team provides a comprehensive set of … , and culturally adapt instruments for completion by patients, caregivers, and clinicians Develop and support …
… in a discrete-choice experiment are asked to choose among treatment options with different sets of benefits and … are relative based on a person’s understanding of their disease state, disease progression, and available therapies, … approach to DCEs ensures actionable results to inform your drug development and market access strategies. For your …
… value it? Willingness-to-pay (WTP) can be estimated using a number of stated-preference methods including … like what’s it worth to a patient if: The dosing regimen changes from 3 times a day to 1? Length of treatment … approach to WTP ensures actionable results to inform your drug development and market access strategies. For your …
… questions—whether the results will be used to inform your drug development and post-approval strategies or place a … Literature reviews can be stand-alone projects such as a disease (including rare disease) or regulatory landscape … clinical development programs. Incidence of adverse events among a patient population or those taking a certain drug. …
… Patient-Centered Outcomes Let us help you understand your drug’s potential for personalized medicine. Drug research focuses on treatment differences and disease differences—much to the exclusion of individual … uncover and understand heterogeneity in treatment response among your patients. These efficient methods allow patterns …